Format

Send to

Choose Destination
J Paediatr Child Health. 2000 Aug;36(4):406-7.

Methaemoglobinaemia secondary to topical lignocaine/ prilocaine in a circumcised neonate.

Author information

1
Department of Paediatrics, University of Adelaide, Women's and Children's Hospital, South Australia, Australia. rcouper@medicine.adelaide.edu.au

Abstract

The use of topical lignocaine/prilocaine (EMLA, Astra Pharmaceuticals, North Ryde, NSW, Australia) for pain relief for neonatal circumcision is becoming more prevalent. Because of immaturity of the methaemoglobin reductase pathway, the neonate is vulnerable to methaemoglobinaemia which is a recognized complication of prilocaine therapy. This is the second report of methaemoglobinaemia due to the use of EMLA in association with circumcision during the newborn period.

PMID:
10940184
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center